International Patent: PHARMACEUTICAL COMPOSITION COMPRISING PTPN2/PTP1B DEGRADING AGENT AND PREPARATION METHOD THEREFOR

GENEVA, Sept. 24 -- NORTHRIDGE HEALTH GROUP (HONG KONG) CO., LIMITED filed a patent application (CN2026/083923) for “PHARMACEUTICAL COMPOSITION COMPRISING PTPN2/PTP1B DEGRADING AGENT AND PREPARATION METHOD THEREFOR”. With publication no. WO/2026/194871, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: A61K 31/4545

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....